Skip to main navigation Skip to search Skip to main content

The aryl hydrocarbon receptor: structure, signaling, physiology and pathology

  • Xavier Coumoul
  • , Robert Barouki
  • , Charlotte Esser
  • , Thomas Haarmann-Stemmann
  • , B. Paige Lawrence
  • , Jörg Lehmann
  • , Pedro Moura-Alves
  • , Iain A. Murray
  • , Christiane A. Opitz
  • , Gary H. Perdew
  • , William Bourguet

Research output: Contribution to journal › Review article › peer-review

Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor of the bHLH/PAS protein family. In this review, we explore the multifaceted roles of AHR in both health and disease, tracing its recognition as a xenobiotic sensor and a central regulator of physiological homeostasis. We begin by recounting six decades of discoveries that have shaped our understanding of AHR, from its canonical function in environmental sensing to its critical roles in development, immune regulation, barrier tissue integrity, and host–microbe interactions. We detail recent structural breakthroughs that have illuminated the ligand-binding mechanisms and regulation of AHR, providing key insights into its activation and transcriptional control. We also highlight the diversity of AHR ligands, ranging from environmental toxins to microbial and dietary metabolites of tryptophan, and their context-dependent effects on AHR activation through the canonical pathway and noncanonical signaling mechanisms. We examine the involvement of AHR in pathologies such as cancer and autoimmune and inflammatory diseases and its potential as a therapeutic target. Finally, emphasis is placed on recent advances and future developments in drug design, aiming to develop modulators with clinical efficacy. This comprehensive synthesis underscores the dual role of AHR as a master integrator of both environmental and endogenous cues. Placing AHR within broader frameworks, such as the exposome, opens new avenues for therapeutic innovation and more effective strategies for disease prevention.

Original languageEnglish (US)
Article number20
JournalSignal Transduction and Targeted Therapy
Volume11
Issue number1
DOIs
StatePublished - Dec 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Genetics
  • Cancer Research

Fingerprint

Dive into the research topics of 'The aryl hydrocarbon receptor: structure, signaling, physiology and pathology'. Together they form a unique fingerprint.

Cite this